There are some findings presenting that fatty acid translocase (FAT/CD36) expression, which is important fatty acid transporter, is increased in patients with nonalcoholic fatty liver disease and CD36 is involved in increased FFA uptake [10]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.